| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Revenue | $79.2M | +13.1% |
| Cost of Revenue | $33.0M | +22.7% |
| Gross Profit | $46.2M | +7.1% |
| R&D Expense | $6.9M | +19.6% |
| SG&A Expense | $20.9M | -6.3% |
| Operating Income | -$70.7M | -1253.6% |
| Pre-tax Income | -$69.4M | -659.0% |
| Income Tax | -$4.7M | -289.6% |
| Net Income | -$64.7M |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.9M | +199.2% |
| Short-term Investments | $1.5M | -84.9% |
| Accounts Receivable | $9.7M | +6.4% |
| Current Assets | $51.5M | +31.0% |
| Total Assets | $131.9M | -32.9% |
| Current Liabilities | $6.7M | -44.3% |
| Total Liabilities | $7.1M | -49.8% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.1M | +36.1% |
| Capital Expenditures | $713K | +26.0% |
| Investing Cash Flow | $3.6M | +106.6% |
| Financing Cash Flow | -$1.1M | +82.5% |
| Free Cash Flow | $17.4M | +36.5% |
| -750.2% |
| EPS (Basic) | -$3.22 | -744.0% |
| EPS (Diluted) | -$3.22 | -757.1% |
| Stockholders' Equity |
| $124.8M |
| -31.6% |